GLP1R and diabetes mellitus: Several studies from the laboratory of Dr. Q. Wang have used “plasmid-based, electroporation-enhanced intramuscular gene therapy” to target delivery of vectors encoding GLP-1 or exendin-4 fusion proteins into mouse models of DM [46–48].